Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02580305
Brief Title: SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

First Submitted : October 17, 2015
First Submitted that Met QC Criteria : October 17, 2015
First Posted : October 20, 2015 (Estimate)

Certification/Extension First Submitted : November 3, 2020
Certification/Extension First Submitted that Met QC Criteria : November 3, 2020
Certification/Extension First Posted : November 5, 2020

Last Update Submitted that Met QC Criteria : November 20, 2020
Last Update Posted : November 23, 2020